• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌根治性肝切除术后浆膜侵犯与复发密切相关:214例连续病例的回顾性研究

Serosal invasion strongly associated with recurrence after curative hepatic resection of hepatocellular carcinoma: a retrospective study of 214 consecutive cases.

作者信息

Sonohara Fuminori, Nomoto Shuji, Inokawa Yoshikuni, Kanda Mitsuro, Yamada Suguru, Fujii Tsutomu, Sugimoto Hiroyuki, Kodera Yasuhiro

机构信息

From the Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine (FS, SN, YI, MK, SY, TF, HS, YK); and Department of Surgery, Aichi-Gakuin University School of Dentistry, Nagoya, Japan (FS, SN, YI).

出版信息

Medicine (Baltimore). 2015 Mar;94(9):e602. doi: 10.1097/MD.0000000000000602.

DOI:10.1097/MD.0000000000000602
PMID:25738484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4553956/
Abstract

The purpose of this study was to clarify the individual prognostic factors after curative and primary resection of hepatocellular carcinoma (HCC).Reliable prognostic factors and tumor staging for HCC have been required to predict an appropriate prognosis. However, in HCC, no staging system has received universal acceptance, and several tumor factors seem to relate to HCC prognosis, but they are not definitive. At present, few studies have mentioned the importance of serosal invasion as a prognostic factor.A retrospective search of our database identified 214 consecutive patients who underwent primary and curative hepatectomy for HCC at our department between January 1998 and December 2011. Risk factors for recurrence-free survival (RFS) and overall survival (OS) were analyzed with Cox proportional hazard model, Kaplan-Meier method, and log-rank tests.Multivariate analyses showed that serosal invasion (hazard ratio [HR], 2.75; P = 0.0005) and vascular invasion (HR, 1.71; P = 0.0331) were independently correlated with RFS. Serosal invasion was significantly correlated with HCC recurrence (P = 0.0230). The Kaplan-Meier method and log-rank tests revealed that the patients with serosal invasion showed significantly worse prognosis both in RFS (P < 0.0001) and OS (P = 0.0016).Serosal invasion should be regarded as a strong independent predictor for recurrence in curatively resected HCC cases.

摘要

本研究的目的是阐明肝细胞癌(HCC)根治性初次切除术后的个体预后因素。需要可靠的HCC预后因素和肿瘤分期来预测合适的预后。然而,在HCC中,没有一种分期系统得到普遍认可,并且有几种肿瘤因素似乎与HCC预后相关,但并不确定。目前,很少有研究提及浆膜侵犯作为预后因素的重要性。对我们的数据库进行回顾性检索,确定了1998年1月至2011年12月期间在我科连续接受HCC根治性初次肝切除术的214例患者。采用Cox比例风险模型、Kaplan-Meier法和对数秩检验分析无复发生存期(RFS)和总生存期(OS)的危险因素。多因素分析显示,浆膜侵犯(风险比[HR],2.75;P = 0.0005)和血管侵犯(HR,1.71;P = 0.0331)与RFS独立相关。浆膜侵犯与HCC复发显著相关(P = 0.0230)。Kaplan-Meier法和对数秩检验显示,浆膜侵犯患者的RFS(P < 0.0001)和OS(P = 0.0016)预后均显著较差。浆膜侵犯应被视为根治性切除HCC病例复发的强大独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18cd/4553956/2676c17d3c09/medi-94-e602-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18cd/4553956/2676c17d3c09/medi-94-e602-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18cd/4553956/2676c17d3c09/medi-94-e602-g005.jpg

相似文献

1
Serosal invasion strongly associated with recurrence after curative hepatic resection of hepatocellular carcinoma: a retrospective study of 214 consecutive cases.肝细胞癌根治性肝切除术后浆膜侵犯与复发密切相关:214例连续病例的回顾性研究
Medicine (Baltimore). 2015 Mar;94(9):e602. doi: 10.1097/MD.0000000000000602.
2
The Impact of Serosal Invasion on Prognosis after Curative Hepatectomy for Hepatocellular Carcinoma: Invasion to Adjacent Organs and Rupture of Tumor Were Crucial Tumor-Related Prognostic Factors Needed for Survival.肝细胞癌根治性肝切除术后浆膜侵犯对预后的影响:侵犯邻近器官和肿瘤破裂是生存所需的关键肿瘤相关预后因素。
Dig Surg. 2018;35(2):155-163. doi: 10.1159/000477270. Epub 2017 Aug 9.
3
Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection.基于炎症的预后评分作为肝细胞癌根治性切除术后肿瘤复发预测指标的比较
J Hepatobiliary Pancreat Sci. 2014 Sep;21(9):682-8. doi: 10.1002/jhbp.114. Epub 2014 May 14.
4
Proposal of invasiveness score to predict recurrence and survival after curative hepatic resection for hepatocellular carcinoma.预测肝细胞癌根治性肝切除术后复发和生存的侵袭性评分方案
Surgery. 1997 Sep;122(3):571-7. doi: 10.1016/s0039-6060(97)90130-6.
5
Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.根治性意向下接受部分肝切除术的肝细胞癌患者无病生存和总生存的预后因素。
Langenbecks Arch Surg. 2018 Nov;403(7):851-861. doi: 10.1007/s00423-018-1715-9. Epub 2018 Sep 28.
6
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
7
Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma.影响孤立性小肝细胞癌患者术后生存的预后因素。
Chin J Cancer. 2016 Aug 16;35(1):80. doi: 10.1186/s40880-016-0143-x.
8
[Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].[不同中国肝癌分期肝细胞癌患者根治性肝切除术后的临床疗效及预后因素分析]
Zhonghua Wai Ke Za Zhi. 2021 Feb 1;59(2):134-143. doi: 10.3760/cma.j.cn112139-20200803-00605.
9
Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion.肿瘤大小不独立影响无肉眼血管侵犯的单发肝细胞癌根治性切除术后的长期生存。
World J Surg. 2014 Apr;38(4):947-57. doi: 10.1007/s00268-013-2365-2.
10
Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection.直径大于10厘米的巨大肝细胞癌在根治性切除术后会导致远处复发,从而使预后恶化。
J Surg Oncol. 2017 Mar;115(3):324-329. doi: 10.1002/jso.24501. Epub 2017 Feb 13.

引用本文的文献

1
Glisson's capsule invasion as a risk factor of multifocal intrahepatic recurrence after hepatectomy for hepatocellular carcinoma: a retrospective single-center cohort study.肝切除术后肝细胞癌多灶性肝内复发的危险因素:Glisson囊侵犯——一项回顾性单中心队列研究
Updates Surg. 2025 Aug 6. doi: 10.1007/s13304-025-02250-w.
2
Liver resection in patients with a history of local ablation for hepatocellular carcinoma has the risk of poor survival and serosal invasion.有肝细胞癌局部消融病史的患者进行肝切除存在生存不良和浆膜侵犯的风险。
Ann Gastroenterol Surg. 2024 Nov 18;9(2):347-358. doi: 10.1002/ags3.12872. eCollection 2025 Mar.
3

本文引用的文献

1
Long-term survival analysis of liver transplantation for hepatocellular carcinoma with bile duct tumor thrombus.伴有胆管癌栓的肝细胞癌肝移植长期生存分析
Transplant Proc. 2014 Apr;46(3):774-7. doi: 10.1016/j.transproceed.2013.10.053.
2
TNM/Okuda/Barcelona/UNOS/CLIP International Multidisciplinary Classification of Hepatocellular Carcinoma: concepts, perspectives, and radiologic implications.肝细胞癌的TNM/奥田/巴塞罗那/UNOS/CLIP国际多学科分类:概念、观点及放射学意义
Abdom Imaging. 2014 Oct;39(5):1070-87. doi: 10.1007/s00261-014-0130-0.
3
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
Prognostic Role of the Intrahepatic Lymphatic System in Liver Cancer.
肝内淋巴系统在肝癌中的预后作用
Cancers (Basel). 2023 Apr 4;15(7):2142. doi: 10.3390/cancers15072142.
4
Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis.肝切除术联合膈肌切除术治疗累及膈肌的肝细胞癌:倾向评分匹配分析。
Ann Surg Oncol. 2020 Oct;27(11):4153-4163. doi: 10.1245/s10434-020-08754-6. Epub 2020 Jun 25.
5
Diabetes, an independent poor prognostic factor of non-B non-C hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylation.糖尿病是乙型肝炎和丙型肝炎以外的肝细胞癌的一个独立的预后不良因素,与二氢嘧啶酶样 3 启动子甲基化相关。
Sci Rep. 2020 Jan 24;10(1):1156. doi: 10.1038/s41598-020-57883-1.
6
Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.循环 microRNAs 作为肝细胞癌潜在的诊断和预后生物标志物。
Sci Rep. 2019 Jul 18;9(1):10464. doi: 10.1038/s41598-019-46872-8.
7
Perioperative and prognostic implication of albumin-bilirubin-TNM score in Child-Pugh class A hepatocellular carcinoma.白蛋白-胆红素-TNM评分在Child-Pugh A级肝细胞癌中的围手术期及预后意义
Ann Gastroenterol Surg. 2018 Sep 27;3(1):65-74. doi: 10.1002/ags3.12212. eCollection 2019 Jan.
2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
4
Hepatocellular carcinoma: current management and perspectives for the future.肝细胞癌:当前的治疗管理与未来展望。
Ann Surg. 2011 Mar;253(3):453-69. doi: 10.1097/SLA.0b013e31820d944f.
5
Lymph circulation in the liver.肝脏中的淋巴循环。
Anat Rec (Hoboken). 2008 Jun;291(6):643-52. doi: 10.1002/ar.20681.
6
Results of 404 hepatic resections including 80 repeat hepatectomies for hepatocellular carcinoma.404例肝切除术的结果,其中包括80例针对肝细胞癌的再次肝切除术。
Hepatogastroenterology. 2006 Sep-Oct;53(71):736-41.
7
Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old.频繁局部消融治疗对肝癌肝切除术后肝内复发患者长期生存的影响:一项对610例16岁以上患者的分析
Ann Surg. 2006 Aug;244(2):265-73. doi: 10.1097/01.sla.0000217921.28563.55.
8
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma.一项比较经皮局部消融治疗与部分肝切除术治疗小肝细胞癌的前瞻性随机试验。
Ann Surg. 2006 Mar;243(3):321-8. doi: 10.1097/01.sla.0000201480.65519.b8.
9
Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.肿块型肝内胆管癌TNM分期中的浆膜侵犯
J Hepatobiliary Pancreat Surg. 2005;12(6):479-83. doi: 10.1007/s00534-005-1026-8.
10
Global cancer statistics, 2002.2002年全球癌症统计数据。
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108. doi: 10.3322/canjclin.55.2.74.